MEDTRONIC PUERTO RICO OPERATIONS CO. ACTIVA; STIMULATOR, ELECTRICAL, IMPLANTED, FOR PARKINS
|
Back to Search Results |
|
Model Number 37612 |
Device Problems
Failure to Deliver Energy (1211); Improper or Incorrect Procedure or Method (2017); Battery Problem (2885)
|
Patient Problems
Convulsion/Seizure (4406); Insufficient Information (4580)
|
Event Type
malfunction
|
Event Description
|
It was reported that the patient had gone to the clinic for a botox injection and the rep was there for another case.After they were called to examine the patient they heard strange noises coming from the patient's head.They did an impedance test and all the values were normal, then they noticed that stimulation was off.The implantable neurostimulator (ins) had shown 100% charge and the last time they charged was 3 days ago, for about a quarter of an hour.The last meeting they had in april everything was fine.They then turned on the ins.The patient's caregiver reported several times that the patient entered a state of stagnation where they rolled their eyes and would sometimes fall.One time the patient fell and the rep caught them before falling, and at that time heard noises from the patient's head.The issue was resolved when the ins was turned back on.
|
|
Manufacturer Narrative
|
Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
|
|
Manufacturer Narrative
|
Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
|
|
Manufacturer Narrative
|
Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
|
|
Event Description
|
Additional information was received: it was reported that when the patient came to the neurologist in april it was for a botox injection online consultation and not for the ins test, so no interrogation happened there.All reports of the patient's falls and rolling of their eyes occurred according to the caregiver at the patient's home.The day the rep was in the clinic they were there for another case and the patient was there for their botox injections and they heard about the seizures they were having, so reports were gathered.There was indication that there was no use of the ins for the past six months and it was not active due to not charging.The noises coming from the patient's head weren't determined.Additional information received: it was reported that there was no specific/strange screen beyond the normal recharge screen, and no error codes when interrogating.Reports had shown that on december 26, 2021 the stimulation was lost due to the ins being discharged.
|
|
Search Alerts/Recalls
|
|
|